🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To demonstrate bioequivalence of a 2.5 mg saxagliptin/1000 mg metformin (gl...
Status
Completed
Location
Mds Pharma Services
Start Date
2009-06
Trial ID
NCT00897390
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics of Saxaglipti...
Status
Terminated
Location
Osborne Research Center
Start Date
2012-09
Trial ID
NCT01525225
To demonstrate bioequivalence of a 2.5 mg saxagliptin/850 mg metformin fixe...
Status
Completed
Location
PPD Development, LP
Start Date
2010-02
Trial ID
NCT01068743
Treatments Being Tested
To evaluate the positive efficacy trend among doses of saxagliptin (BMS-477...
Status
Completed
Location
Multiple Locations
Start Date
2003-05
Trial ID
NCT00950599
Treatments Being Tested
The purpose of the study is to examine the effect of Saxagliptin in the new...
Status
Unknown
Location
Shandong Provincial Hospital
Start Date
2013-08
Trial ID
NCT01960205
Treatments Being Tested
To demonstrate bioequivalence of a 2.5 mg saxagliptin/500 mg metformin (glu...
Status
Completed
Location
Mds Pharma Services
Start Date
2009-06
Trial ID
NCT00899470
The purpose of this clinical research study is to learn whether Saxagliptin...
Status
Completed
Location
Winston Technology, Inc.
Start Date
2006-03
Trial ID
NCT00295633
Treatments Being Tested
The purpose of this clinical research study is to learn whether Saxagliptin...
Status
Completed
Location
Local Institution
Start Date
2005-08
Trial ID
NCT00121667
To evaluate the efficacy, safety, tolerability, of Saxagliptin (BMS-477118)...
Status
Completed
Location
Research Site
Start Date
2012-05
Trial ID
NCT01434186
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, tolerability...
Status
Completed
Location
Research Site
Start Date
2011-06
Trial ID
NCT01204775
Treatments Being Tested